Callahan Advisors’s Celgene Corp CELG Stock Holding History

Callahan Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,800	Closed	-$278K	–	142
2019 Q3	$278K	Sell	2,800 -8,127	-74%	-$772K	0.05%	119
2019 Q2	$1.01M	Sell	10,927 -17,906	-62%	-$1.7M	0.18%	82
2019 Q1	$2.72M	Sell	28,833 -687	-2%	-$60.1K	0.51%	53
2018 Q4	$1.89M	Sell	29,520 -4,945	-14%	-$365K	0.4%	55
2018 Q3	$3.08M	Buy	34,465 +30,485	+766%	+$2.69M	0.57%	53
2018 Q2	$316K	Buy	+3,980	New	+$330K	0.06%	109

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Callahan Advisors's CELG Position: Q4 2019 in Review

Callahan Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,800 shares — an estimated $278K sold.

Callahan Advisors first reported a position in CELG in Q2 2018 and held it in 6 quarters. The position peaked at $3.08M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Callahan Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Callahan Advisors sold 2,800 Celgene Corp shares in Q4 2019, an estimated $278K.
Callahan Advisors first reported a position in Celgene Corp in Q2 2018 and held it in 6 quarters.
Callahan Advisors's Celgene Corp position peaked at $3.08M in Q3 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Callahan Advisors's 13F filing for Q4 2019, filed 21 Jan 2020.